TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/29/25 19:30 | 9/29/25 | KURA | Kura Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bair Teresa Brophy | CA | O | GC | S | -79 | 8.94 | 0 | -9 | -6 | 148 | D | ||||||||||||||
5/19/25 18:30 | 5/19/25 | KURA | Kura Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bair Teresa Brophy | CA | O | GC | S | -9 | 5.96 | 0 | -2 | -1 | 108 | D | ||||||||||||||
1/28/25 20:38 | 1/28/25 | KURA | Kura Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bair Teresa Brophy | CA | O | GC | S | -57 | 7.87 | 0 | -7 | -6 | 108 | D | ||||||||||||||
5/20/24 18:30 | 5/20/24 | KURA | Kura Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bair Teresa Brophy | CA | O | GC | S | -58 | 22.15 | 0 | -3 | -4 | 69 | D | ||||||||||||||
1/31/24 17:30 | 1/29/24 | KURA | Kura Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bair Teresa Brophy | CA | O | GC | S | -37 | 17.80 | 0 | -2 | -3 | 69 | D | ||||||||||||||
11/18/22 16:53 | 11/17/22 | KURA | Kura Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bair Teresa Brophy | CA | O | GC | S | -32 | 15.22 | 0 | -2 | -100 | 0 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |